Case Based Peer Perspectives

Tomasz M. Beer, MD, FACP, reviews key clinical trial data and treatment options for the management of metastatic castration-resistant prostate cancer (mCRPC).

Alan Skarbnik, MD, reviews the case of a 60-year-old man with follicular lymphoma and provides a discussion on treatment considerations and challenges.

Alicia Morgans, MD, MPH provides insight on the treatment of mCRPC with lutetium-177-PSMA-617 in recurrent setting.

Kanwal Raghav, MBBS, MD, discusses the case of a 72-year-old woman with metastatic colorectal cancer and explains the possible therapy options.

Tanios Bekaii-Saab, MD, FACP, presents a case study involving a 65-year-old patient diagnosed with stage 4 metastatic colorectal cancer and provides an in-depth discussion on the most effective therapy options for the disease.

Lyndsay Willmott, MD, discusses the case of a 57-year-old woman with ovarian cancer and the available treatment options.

Dr Ramez Eskander, an expert gynecologist oncologist, reviews the case of a 64-year-old woman with advanced ovarian cancer.

Expert perspectives on the optimal management of a woman who is diagnosed and relapses with diffuse large B-cell lymphoma.

Perry Cook, MD, reviews the case of a 76-year-old man with relapsed/refractory follicular lymphoma and provides a discussion on treatment considerations and challenges.

Pierre Gholam, MD, reviews significant clinical trial data and treatment options for the management of unresectable HCC.

Laurie Sehn, MD, presents the case of a 76-year-old man with relapsed diffuse B-cell lymphoma and highlights the treatment options available to patients.

Andrew Zelenetz, MD, reviews the diagnosis and treatment plan for a 77-year-old man with relapsed chronic lymphocytic leukemia (CLL) while highlighting several treatment options.

An expert in hematology oncology, Jeff Sharman, MD, reviews the case of a 73-year-old woman with chronic lymphocytic leukemia (CLL) and shares key insights into factors to consider when selecting first- and second-line treatment.

Ghassan K. Abou-Alfa, MD, MBA, reviews key clinical trial data and treatment options for the management of unresectable HCC.

Thought leader in thoracic oncology, Hossein Borghaei, DO, reviews the case of a 59-year-old man with extensive-stage small-cell lung cancer and discusses the current treatment landscape by highlighting key clinical trial data on the safety and efficacy of lurbinectedin.

Loretta Nastoupil, MD, provides insights into the contemporary and future treatment options for a patient with relapsed/refractory follicular lymphoma (R/R FL).

Thought leader in thoracic oncology, Jared Weiss, MD, reviews the case of a 64-year-old woman with extensive-stage small-cell lung cancer and discusses the current treatment landscape by highlighting key clinical trial data on the safety and efficacy of lurbinectedin.

John Marshall, MD, reviews the case of a patient with metastatic HER2+ (human epidermal growth factor receptor 2) cancer of the gastroesophageal junction.

John Burke, MD, reviews the case of a 76-year-old man with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) while analyzing current and future treatment options in R/R DLBCL.

Chirag Shah, MD, MPH, an expert in gynecologic oncology, reviews the case of a 67-year-old woman with ovarian cancer and discusses factors to consider when selecting therapy including the recent results of the PRIMA and NOVA trials of niraparib in patients with ovarian cancer.

Clifton C. Mo, MD, provides insight on the management of multiple myeloma and evaluates the role of current treatment regimens.

Kami Maddocks, MD, reviews the case of a 74-year-old man with relapsed/refractory follicular lymphoma and discusses current treatment options.

Rafael Fonseca, MD, discusses the case of a 77-year-old woman with multiple myeloma, treatment approach for patients with newly diagnosed multiple myeloma, and the trials providing insight into the treatment of this disease.

Matthew Lunning, DO, presents a case study of a 71-year-old woman with relapsed/refractory diffuse large B-cell lymphoma.

Karen Reckamp, MD, comments on the management and treatment of a 68-year-old woman with ALK+ NSCLC, as well as data demonstrated in the ALTA-1L trial, use of brigatinib, and her own clinical experiences.

Joshua M. Bauml, MD, provides insight on the treatment of ALK fusion+ non-small cell lung cancer with tyrosine kinase inhibitors.

Erin Crane, MD, reviews the case of a 63-year-old woman with recurrent ovarian cancer and discusses treatment options, the Phase 3 NOVA trial, and the future of ovarian cancer treatment.

Natalie Callander, MD, presents a case of a 68-year-old man with multiple myeloma.

Adriana Rossi, MD, describes the treatment approach in caring for a 75-year-old woman with triple-class refractory multiple myeloma [RRMM] while highlighting results from the relevant DREAMM and SOHO studies.

A key opinion leader in hematology, Jonathan Kaufman, MD, provides insight into the case of a 75-year-old man with multiple myeloma and discusses treatment considerations, standard of care therapies, and recent clinical trial updates for the management of multiple myeloma.